124 related articles for article (PubMed ID: 27365293)
21. Oncostatin M overexpression induces skin inflammation but is not required in the mouse model of imiquimod-induced psoriasis-like inflammation.
Pohin M; Guesdon W; Mekouo AA; Rabeony H; Paris I; Atanassov H; Favot L; Mcheik J; Bernard FX; Richards CD; Amiaud J; Blanchard F; Lecron JC; Morel F; Jégou JF
Eur J Immunol; 2016 Jul; 46(7):1737-51. PubMed ID: 27122058
[TBL] [Abstract][Full Text] [Related]
22. The severity of imiquimod-induced mouse skin inflammation is independent of endogenous IL-38 expression.
Palomo J; Troccaz S; Talabot-Ayer D; Rodriguez E; Palmer G
PLoS One; 2018; 13(3):e0194667. PubMed ID: 29554104
[TBL] [Abstract][Full Text] [Related]
23. Double deficiency of Trex2 and DNase1L2 nucleases leads to accumulation of DNA in lingual cornifying keratinocytes without activating inflammatory responses.
Manils J; Fischer H; Climent J; Casas E; García-Martínez C; Bas J; Sukseree S; Vavouri T; Ciruela F; de Anta JM; Tschachler E; Eckhart L; Soler C
Sci Rep; 2017 Sep; 7(1):11902. PubMed ID: 28928425
[TBL] [Abstract][Full Text] [Related]
24. Resolvin D1 attenuates imiquimod-induced mice psoriasiform dermatitis through MAPKs and NF-κB pathways.
Xu J; Duan X; Hu F; Poorun D; Liu X; Wang X; Zhang S; Gan L; He M; Zhu K; Ming Z; Chen H
J Dermatol Sci; 2018 Feb; 89(2):127-135. PubMed ID: 29137840
[TBL] [Abstract][Full Text] [Related]
25. Increased βTrCP are associated with imiquimod-induced psoriasis-like skin inflammation in mice via NF-κB signaling pathway.
Li R; Wang J; Wang X; Zhou J; Wang M; Ma H; Xiao S
Gene; 2016 Oct; 592(1):164-171. PubMed ID: 27476970
[TBL] [Abstract][Full Text] [Related]
26. Paeoniflorin inhibits imiquimod-induced psoriasis in mice by regulating Th17 cell response and cytokine secretion.
Zhao J; Di T; Wang Y; Wang Y; Liu X; Liang D; Li P
Eur J Pharmacol; 2016 Feb; 772():131-43. PubMed ID: 26738780
[TBL] [Abstract][Full Text] [Related]
27. Osteopontin deficiency affects imiquimod-induced psoriasis-like murine skin inflammation and lymphocyte distribution in skin, draining lymph nodes and spleen.
Frenzel DF; Borkner L; Scheurmann J; Singh K; Scharffetter-Kochanek K; Weiss JM
Exp Dermatol; 2015 Apr; 24(4):305-7. PubMed ID: 25655893
[TBL] [Abstract][Full Text] [Related]
28. Antiproliferation of keratinocytes and alleviation of psoriasis by the ethanol extract of Artemisia capillaris.
Lee SY; Nam S; Hong IK; Kim H; Yang H; Cho HJ
Phytother Res; 2018 May; 32(5):923-932. PubMed ID: 29377339
[TBL] [Abstract][Full Text] [Related]
29. Spread of Psoriasiform Inflammation to Remote Tissues Is Restricted by the Atypical Chemokine Receptor ACKR2.
Shams K; Wilson GJ; Singh M; van den Bogaard EH; Le Brocq ML; Holmes S; Schalkwijk J; Burden AD; McKimmie CS; Graham GJ
J Invest Dermatol; 2017 Jan; 137(1):85-94. PubMed ID: 27568525
[TBL] [Abstract][Full Text] [Related]
30. RIPK1 downregulation in keratinocyte enhances TRAIL signaling in psoriasis.
Saito N; Honma M; Shibuya T; Iinuma S; Igawa S; Kishibe M; Ishida-Yamamoto A
J Dermatol Sci; 2018 Jul; 91(1):79-86. PubMed ID: 29661487
[TBL] [Abstract][Full Text] [Related]
31. Protective effects of agonistic anti-4-1BB antibody on the development of imiquimod-induced psoriasis-like dermatitis in mice.
Yoo JK; Choo YK; Kwak DH; Lee JM; Lim CY; Lee JH; Park MY; Kim CH
Immunol Lett; 2016 Oct; 178():131-9. PubMed ID: 27592361
[TBL] [Abstract][Full Text] [Related]
32. Mannan-binding lectin promotes keratinocyte to produce CXCL1 and enhances neutrophil infiltration at the early stages of psoriasis.
Zeng J; Chen X; Lei K; Wang D; Lin L; Wang Y; Li Y; Liu Y; Zhang L; Zuo D; Sun L
Exp Dermatol; 2019 Sep; 28(9):1017-1024. PubMed ID: 31260126
[TBL] [Abstract][Full Text] [Related]
33. SLC35E1 promotes keratinocyte proliferation in psoriasis by regulating zinc homeostasis.
Huang T; Chen S; Ding K; Zheng B; Lv W; Wang X; Zhong Y; Huang H; Zhang X; Ma S; Yang B; Wang X; Rong Z
Cell Death Dis; 2023 Jun; 14(6):354. PubMed ID: 37296095
[TBL] [Abstract][Full Text] [Related]
34. Paeonol ameliorates imiquimod-induced psoriasis-like skin lesions in BALB/c mice by inhibiting the maturation and activation of dendritic cells.
Meng Y; Wang M; Xie X; Di T; Zhao J; Lin Y; Xu X; Li N; Zhai Y; Wang Y; Li P
Int J Mol Med; 2017 May; 39(5):1101-1110. PubMed ID: 28339016
[TBL] [Abstract][Full Text] [Related]
35. MicroRNA-146a suppresses IL-17-mediated skin inflammation and is genetically associated with psoriasis.
Srivastava A; Nikamo P; Lohcharoenkal W; Li D; Meisgen F; Xu Landén N; Ståhle M; Pivarcsi A; Sonkoly E
J Allergy Clin Immunol; 2017 Feb; 139(2):550-561. PubMed ID: 27568078
[TBL] [Abstract][Full Text] [Related]
36. TRIM21 is important in the early phase of inflammation in the imiquimod-induced psoriasis-like skin inflammation mouse model.
Vinter H; Langkilde A; Ottosson V; Espinosa A; Wahren-Herlenius M; Raaby L; Johansen C; Iversen L
Exp Dermatol; 2017 Aug; 26(8):713-720. PubMed ID: 27943421
[TBL] [Abstract][Full Text] [Related]
37. Imiquimod-induced psoriasis-like skin inflammation is suppressed by BET bromodomain inhibitor in mice through RORC/IL-17A pathway modulation.
Nadeem A; Al-Harbi NO; Al-Harbi MM; El-Sherbeeny AM; Ahmad SF; Siddiqui N; Ansari MA; Zoheir KM; Attia SM; Al-Hosaini KA; Al-Sharary SD
Pharmacol Res; 2015 Sep; 99():248-57. PubMed ID: 26149470
[TBL] [Abstract][Full Text] [Related]
38. A comparison of the effects of topical treatment of calcipotriol, camptothecin, clobetasol and tazarotene on an imiquimod-induced psoriasis-like mouse model.
Sun J; Dou W; Zhao Y; Hu J
Immunopharmacol Immunotoxicol; 2014 Feb; 36(1):17-24. PubMed ID: 24286371
[TBL] [Abstract][Full Text] [Related]
39. Oral Administration of Vanillin Improves Imiquimod-Induced Psoriatic Skin Inflammation in Mice.
Cheng HM; Chen FY; Li CC; Lo HY; Liao YF; Ho TY; Hsiang CY
J Agric Food Chem; 2017 Nov; 65(47):10233-10242. PubMed ID: 29073354
[TBL] [Abstract][Full Text] [Related]
40. Astilbin inhibits Th17 cell differentiation and ameliorates imiquimod-induced psoriasis-like skin lesions in BALB/c mice via Jak3/Stat3 signaling pathway.
Di TT; Ruan ZT; Zhao JX; Wang Y; Liu X; Wang Y; Li P
Int Immunopharmacol; 2016 Mar; 32():32-38. PubMed ID: 26784569
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
